Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
N-methylation of peptides: A new perspective in medicinal chemistry
These findings provide preclinical validation for the use of anti-GIPR antibodies in the treatment of obesity
Other GLP-1 drugs like Wegovy and Zepbound were developed and tested specifically for obesity treatment with higher doses optimized for weight management outcomes
Study design To test the hypothesis, we designed a 16-week, single-blinded, randomized, placebo-controlled clinical trial, to compare the effects of semaglutide versus placebo in women, diagnosed with obesity and polycystic ovarian syndrome (PCOS)
In: Proceedings from the European Society of Cardiology
Clean, smart, and effective - so you can shine brighter every day
US$ 22.37
US$ 22.04
US$ 29.91
US$ 20.31
US$ 25.59
